| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.06 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |